These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27115268)

  • 1. Safety of Testosterone Replacement Therapy.
    JAMA; 2016 Apr; 315(14):1512-3. PubMed ID: 27115268
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of testosterone replacement therapy in adolescents with Klinefelter syndrome.
    Mehta A; Clearman T; Paduch DA
    J Urol; 2014 May; 191(5 Suppl):1527-31. PubMed ID: 24679877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounded Testosterone Troches TO OPTIMIZE HEALTH AND THE TESTOSTERONE CONTROVERSY.
    Guth MA
    Int J Pharm Compd; 2015; 19(3):195-203. PubMed ID: 26714360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and heart failure.
    Malkin CJ; Channer KS; Jones TH
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):262-8. PubMed ID: 20404724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy.
    Hsieh TC; Pastuszak AW; Hwang K; Lipshultz LI
    J Urol; 2013 Feb; 189(2):647-50. PubMed ID: 23260550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
    Kaplan AL; Hu JC
    Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Patient with testosterone deficit syndrome after radical prostatectomy].
    Linares Espinós E; Martínez-Salamanca JI; Morgentaler A; Moncada I; del Portillo L; Rodríguez-Izquierdo M; Areche J; Carballido J
    Arch Esp Urol; 2013 Sep; 66(7):663-8. PubMed ID: 24047624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of postmenopausal testosterone therapy.
    Maclaran K; Panay N
    Womens Health (Lond); 2012 May; 8(3):263-75. PubMed ID: 22554174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical hypogonadism and androgen replacement therapy: an overview.
    Ohl DA; Quallich SA
    Urol Nurs; 2006 Aug; 26(4):253-9, 269; quiz 260. PubMed ID: 16939042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of testosterone replacement therapy.
    Med Lett Drugs Ther; 2016 Mar; 58(1490):33-4. PubMed ID: 26963153
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
    Slater CC; Zhang C; Hodis HN; Mack WJ; Boostanfar R; Shoupe D; Paulson RJ; Stanczyk FZ
    J Reprod Med; 2001 Dec; 46(12):1052-6. PubMed ID: 11789085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefit and risk of testosterone replacement therapy in older men: effects on lipid metabolism.
    Volpato S; Vigna GB; Fellin R
    Acta Biomed; 2010; 81 Suppl 1():95-9. PubMed ID: 20518198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
    Basaria S; Dobs AS
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.